Biomarker targets and novel therapeutics

Cancer Treat Res. 2009:149:85-105. doi: 10.1007/978-0-387-98094-2_4.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / antagonists & inhibitors*
  • Carcinoma / drug therapy*
  • Clinical Trials as Topic
  • Drug Delivery Systems*
  • Drug Design
  • Drugs, Investigational / pharmacology
  • Drugs, Investigational / therapeutic use
  • Female
  • Humans
  • Immunotherapy
  • Meta-Analysis as Topic
  • Multicenter Studies as Topic
  • Neoplasm Proteins / antagonists & inhibitors*
  • Organoplatinum Compounds / pharmacology
  • Organoplatinum Compounds / therapeutic use
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / therapy
  • Prognosis
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Signal Transduction / drug effects

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Drugs, Investigational
  • Neoplasm Proteins
  • Organoplatinum Compounds
  • Protein Kinase Inhibitors
  • Receptor Protein-Tyrosine Kinases